Table 3 Within-practice comparison of first and second measurement of practices in first cohort and between practice comparison of first and second cohort in 2009-2011
Indicators1 | 1stcohort | Within-group comparison of 1stcohort2 | 2ndcohort | Between-groups comparison 1stand 2ndcohort 2009-20113 | |||
|---|---|---|---|---|---|---|---|
2006-2008 | 2009-2011 | 2009-2011 | |||||
Mean (SD) | Mean (SD) | Estimate (95% conf. int.) | p | Mean (SD) | Estimate (95% conf. int.) | p | |
Diabetes | |||||||
Prevalence | 0.040 (0.014) | 0.050 (0.013) | 0.010 (0.006 - 0.015) | 0.000 | 0.051 (0.018) | -0.001 (-0.006 - 0.005) | 0.79 |
Outcome measures | |||||||
HbA1c < target | 60.8 (15.9) | 63.6 (11.4) | 2.6 (-2.6 - 7.9) | 0.32 | 63.6 (11.0) | -0.02 (-4.0 - 3.9) | 0.99 |
Blood pressure < target4 | 56.6 (16.7) | 52.1 (17.0) | -5.4 (-11.4 - 0.7) | 0.08 | 50.8 (16.7) | 0.9 (-4.9 - 6.7) | 0.76 |
Total cholesterol < target4 | 50.4 (15.0) | 45.2 (20.1) | -5.4 (-12.4 - 1.5) | 0.12 | 36.3 (20.7) | 8.8 (1.5 - 16.1) | 0.02 |
Process measures | |||||||
Mean process score | 79.2 (10.0) | 81.6 (12.7) | 2.3 (-1.5 - 6.1) | 0.23 | 79.5 (12.7) | 1.8 (-2.5 - 6.2) | 0.41 |
HbA1c measurement | 90.4 (10.2) | 92.5 (7.3) | 2.1 (-1.1 - 5.4) | 0.20 | 92.4 (6.7) | -0.03 (-2.5 - 2.4) | 0.98 |
BP5 measurement | 93.7 (7.0) | 91.9 (13.3) | -1.7 (-5.0 - 1.7) | 0.32 | 92.4 (8.9) | -0.7 (-4.7 - 3.3) | 0.74 |
Cholesterol measurement | 81.3 (14.4) | 86.1 (12.4) | 4.8 (0.2 - 9.4) | 0.04 | 86.6 (9.4) | -0.6 (-4.4 - 3.2) | 0.74 |
Creatinine clearance | 82.1 (13.1) | 85.3 (17.0) | 3.4 (-1.2 - 7.9) | 0.14 | 83.6 (17.3) | 1.2 (-4.8 - 7.2) | 0.69 |
Retinal examination | 70.6 (16.4) | 66.4 (24.4) | -4.5 (-12.0 - 3.1) | 0.24 | 62.3 (26.6) | 3.9 (-4.9 - 12.7) | 0.39 |
Feet examination | 57.3 (22.7) | 67.1 (26.4) | 9.7(0.9 - 18.5) | 0.03 | 59.7 (27.1) | 7.2 (-2.1 - 16.5) | 0.13 |
Prescription of lipid lowering medication | 60.5 (16.4) | 69.9 (22.6) | 9.5 (2.5 - 16.4) | 0.009 | 68.4 (13.1) | 1.1 (-5.1 - 7.4) | 0.72 |
Chronic obstructive pulmonary disease (COPD) | |||||||
Prevalence | 0.017 (0.009) | 0.022 (0.008) | 0.005 (0.003 - 0.008) | 0.000 | 0.023 (0.010) | -0.001 (-0.004 - 0.003) | 0.65 |
Outcome measure | |||||||
Patients that smoke | 36.6 (22.9) | 31.8 (16.1) | -4.9 (-11.5 - 1.8) | 0.15 | 32.2 (20.7) | -0.4 (-6.9 - 6.2) | 0.92 |
Process measures | |||||||
Mean process score | 58.5 (17.8) | 67.2 (22.1) | 8.3 (1.8 - 14.8) | 0.01 | 61.6 (24.9) | 5.5 (-2.8 - 13.8) | 0.19 |
Smoke status known | 76.0 (21.4) | 75.4 (23.2) | -1.3 (-8.1 - 5.6) | 0.71 | 69.4 (27.0) | 6.1 (-2.8 - 15.0) | 0.18 |
Spirometry | 41.2 (23.5) | 58.8 (28.7) | 17.0 (8.0 - 26.0) | 0.000 | 53.8 (28.5) | 4.7 (-5.5 - 14.8) | 0.37 |
Stop smoking advice | 47.0 (33.9) | 69.8 (30.8) | 21.8 (8.7 - 34.9) | 0.002 | 65.2 (32.6) | 5.1 (-10.1 - 20.2) | 0.51 |
Cardiovascular disease (CVD) 6 | |||||||
Outcome measures | |||||||
Patients that smoke | - | 12.6 (8.5) | - | - | 10.5 (7.8) | 1.9 (-1.1 - 4.9) | 0.20 |
Blood pressure < target4 | - | 41.8 (15.5) | - | - | 35.7 (14.7) | 6.3 (0.6 - 11.9) | 0.03 |
Process measures | |||||||
Mean process score | - | 61.3 (20.3) | - | - | 54.5 (21.6) | 6.5 (-1.2 - 14.1) | 0.10 |
Smoke status known | - | 51.7 (26.6) | - | - | 39.8 (25.5) | 11.3 (1.9 - 20.8) | 0.02 |
BP5 measurement | - | 70.8 (17.9) | - | - | 69.3 (21.3) | 1.6 (-5.6 - 8.9) | 0.66 |
Stop smoking advice | - | 66.7 (34.2) | - | - | 51.1 (34.0) | 13.2 (-4.6 - 30.9) | 0.14 |
Glucose measurement | - | 77.5 (17.6) | - | - | 64.3 (24.3) | 12.0 (1.9 - 22.0) | 0.02 |
Prescription of anticoagulants | - | 78.8 (15.0) | - | - | 76.5 (20.4) | 1.6 (-5.1 - 8.3) | 0.64 |